Information Library

Flexible outsourcing

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • Re-energizing a Brand

    September 1, 2010
    Learn how Quintiles revamped the consumer marketing plan for an oral health product, boosting brand awareness by 90% and expanding the overall market size.

  • Capital - sharing risks, expanding opportunities

    July 14, 2010
    This Capital brochure reviews how Quintiles helps biopharma allies maximize the value of assets, reduce risk, accelerate outcomes and increase rewards.

  • Doctors and Sales Reps

    July 7, 2010
    Pharmaceutical companies are faced with a difficult question, should they invest in an inhouse sales force to market their product or does it make sense

  • Outsourcing Exceeds Expectations

    June 30, 2010
    In Quintiles, Lilly found an ally with a kindred commitment to a best-in-class culture, plus a readiness to innovate in a challenging market.

  • Syndicated Solutions

    June 30, 2010
    Astellas needed to rapidly ramp up its sales force by 50% to take advantage of a projected $1 billion opportunity. Quintiles provided a new risk.

  • Challenging Traditional Outsourcing Models Using Core And Non-Core Assessment

    June 30, 2010

  • Defining Value

    June 8, 2010
    Market Access, one of the many Consulting services available from Quintiles, stands ready to help you navigate the value substantiation process, from developing and demonstrating your product’s value platform to winning a preferred position on payer formularies and negotiating pricing and reimbursement contracts.

  • Vital Insights

    June 8, 2010
    Quintiles conducted an exhaustive analysis into global and U.S. responses to the use of comparative effectiveness research, identifying key signals to help the customer recognize risk scenarios.

  • The New Health

    May 26, 2010
    Quintiles examines the complex challenges and opportunities facing the bio pharmaceutical industry and how companies must manage risk, demonstrate greater value and improve patient outcomes.

  • Outsourcing as strategic alternative to your own headcount

    May 25, 2010
    Approach of Roche Italy in outsourcing their primary care sales force to Quintiles

Page 1 of 6 (52 results)

Subscribe to Email Based on Your Interests

Set preferences